Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
<h4>Background</h4>In VOICE, a multisite HIV pre-exposure prophylaxis (PrEP) trial, plasma drug levels pointed to widespread product nonuse, despite high adherence estimated by self-reports and clinic product counts. Using a socio-ecological framework (SEF), we explored socio-cultural an...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f9d62bd8e37460ab473ebb3b54a3246 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7f9d62bd8e37460ab473ebb3b54a3246 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7f9d62bd8e37460ab473ebb3b54a32462021-11-18T08:31:34ZWomen's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.1932-620310.1371/journal.pone.0089118https://doaj.org/article/7f9d62bd8e37460ab473ebb3b54a32462014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586534/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>In VOICE, a multisite HIV pre-exposure prophylaxis (PrEP) trial, plasma drug levels pointed to widespread product nonuse, despite high adherence estimated by self-reports and clinic product counts. Using a socio-ecological framework (SEF), we explored socio-cultural and contextual factors that influenced participants' experience of daily vaginal gel and oral tablet regimens in VOICE.<h4>Methods</h4>In Johannesburg, a qualitative ancillary study was concurrently conducted among randomly selected VOICE participants assigned to in-depth interviews (n = 41), serial ethnographic interviews (n = 21), or focus group discussions (n = 40). Audiotaped interviews were transcribed, translated, and coded thematically for analysis.<h4>Results</h4>Of the 102 participants, the mean age was 27 years, and 96% had a primary sex partner with whom 43% cohabitated. Few women reported lasting nonuse, which they typically attributed to missed visits, lack of product replenishments, and family-related travel or work. Women acknowledged occasionally skipping or mistiming doses because they forgot, were busy, felt lazy or bored, feared or experienced side effects. However, nearly all knew or heard of other study participants who did not use products daily. Three overarching themes emerged from further analyses: ambivalence toward research, preserving a healthy status, and managing social relationships. These themes highlighted the profound and complex meanings associated with participating in a blinded HIV PrEP trial and taking antiretroviral-based products. The unknown efficacy of products, their connection with HIV infection, challenges with daily regimen given social risks, lack of support-from partners and significant others-and the relationship tradeoffs entailed by using the products appear to discourage adequate product use.<h4>Conclusions</h4>Personal acknowledgment of product nonuse was challenging. This qualitative inquiry highlighted key influences at all SEF levels that shaped women's perceptions of trial participation and experiences with investigational products. Whether these impacted women's behaviors and may have contributed to ineffective trial results warrants further investigation.Ariane van der StratenJonathan StadlerElizabeth MontgomeryMiriam HartmannBusiswe MagaziFlorence MathebulaKatie SchwartzNicole LabordeLydia Soto-TorresPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 2, p e89118 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Ariane van der Straten Jonathan Stadler Elizabeth Montgomery Miriam Hartmann Busiswe Magazi Florence Mathebula Katie Schwartz Nicole Laborde Lydia Soto-Torres Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. |
description |
<h4>Background</h4>In VOICE, a multisite HIV pre-exposure prophylaxis (PrEP) trial, plasma drug levels pointed to widespread product nonuse, despite high adherence estimated by self-reports and clinic product counts. Using a socio-ecological framework (SEF), we explored socio-cultural and contextual factors that influenced participants' experience of daily vaginal gel and oral tablet regimens in VOICE.<h4>Methods</h4>In Johannesburg, a qualitative ancillary study was concurrently conducted among randomly selected VOICE participants assigned to in-depth interviews (n = 41), serial ethnographic interviews (n = 21), or focus group discussions (n = 40). Audiotaped interviews were transcribed, translated, and coded thematically for analysis.<h4>Results</h4>Of the 102 participants, the mean age was 27 years, and 96% had a primary sex partner with whom 43% cohabitated. Few women reported lasting nonuse, which they typically attributed to missed visits, lack of product replenishments, and family-related travel or work. Women acknowledged occasionally skipping or mistiming doses because they forgot, were busy, felt lazy or bored, feared or experienced side effects. However, nearly all knew or heard of other study participants who did not use products daily. Three overarching themes emerged from further analyses: ambivalence toward research, preserving a healthy status, and managing social relationships. These themes highlighted the profound and complex meanings associated with participating in a blinded HIV PrEP trial and taking antiretroviral-based products. The unknown efficacy of products, their connection with HIV infection, challenges with daily regimen given social risks, lack of support-from partners and significant others-and the relationship tradeoffs entailed by using the products appear to discourage adequate product use.<h4>Conclusions</h4>Personal acknowledgment of product nonuse was challenging. This qualitative inquiry highlighted key influences at all SEF levels that shaped women's perceptions of trial participation and experiences with investigational products. Whether these impacted women's behaviors and may have contributed to ineffective trial results warrants further investigation. |
format |
article |
author |
Ariane van der Straten Jonathan Stadler Elizabeth Montgomery Miriam Hartmann Busiswe Magazi Florence Mathebula Katie Schwartz Nicole Laborde Lydia Soto-Torres |
author_facet |
Ariane van der Straten Jonathan Stadler Elizabeth Montgomery Miriam Hartmann Busiswe Magazi Florence Mathebula Katie Schwartz Nicole Laborde Lydia Soto-Torres |
author_sort |
Ariane van der Straten |
title |
Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. |
title_short |
Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. |
title_full |
Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. |
title_fullStr |
Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. |
title_full_unstemmed |
Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. |
title_sort |
women's experiences with oral and vaginal pre-exposure prophylaxis: the voice-c qualitative study in johannesburg, south africa. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/7f9d62bd8e37460ab473ebb3b54a3246 |
work_keys_str_mv |
AT arianevanderstraten womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica AT jonathanstadler womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica AT elizabethmontgomery womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica AT miriamhartmann womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica AT busiswemagazi womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica AT florencemathebula womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica AT katieschwartz womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica AT nicolelaborde womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica AT lydiasototorres womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica |
_version_ |
1718421692223586304 |